|
Volumn 17, Issue 1, 2006, Pages 39-42
|
The role of intradermal skin testing and patch testing in the diagnosis of autoimmune progesterone dermatitis
|
Author keywords
[No Author keywords available]
|
Indexed keywords
11ALPHA HYDROXYPROGESTERONE;
21ALPHA HYDROXYPROGESTERONE;
AMCINONIDE;
AZATHIOPRINE;
BETAMETHASONE VALERATE;
BUDESONIDE;
CLOBETASOL PROPIONATE;
ESTRADIOL;
ETHINYLESTRADIOL PLUS NORETHISTERONE;
ETHINYLESTRADIOL PLUS NORETHISTERONE ACETATE;
HYDROCORTISONE;
HYDROCORTISONE BUTYRATE;
HYDROXYPROGESTERONE;
MEDROXYPROGESTERONE;
ORAL CONTRACEPTIVE AGENT;
PREDNISOLONE;
PREDNISONE;
PROGESTERONE;
TRIAMCINOLONE ACETONIDE;
UNCLASSIFIED DRUG;
ADULT;
ANAPHYLAXIS;
ARTICLE;
AUTOIMMUNE DISEASE;
AUTOIMMUNE PROGESTERONE DERMATITIS;
CASE REPORT;
CLINICAL FEATURE;
DERMATITIS;
DIFFERENTIATION;
ECZEMA;
ERYTHEMA MULTIFORME;
FEMALE;
FIXED DRUG ERUPTION;
FOLLOW UP;
HISTOLOGY;
HUMAN;
HUMAN TISSUE;
INTRACUTANEOUS TEST;
LUTEAL PHASE;
OVARIECTOMY;
OVULATION INHIBITION;
PATCH TEST;
PRIORITY JOURNAL;
PUNCH BIOPSY;
RASH;
STOMATITIS;
URTICARIA;
VESICULOPUSTULAR ERUPTION;
ADULT;
AUTOIMMUNE DISEASES;
CONTRACEPTIVES, ORAL;
DERMATITIS;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTRADERMAL TESTS;
MENSTRUAL CYCLE;
PATCH TESTS;
PROGESTERONE;
RISK ASSESSMENT;
SENSITIVITY AND SPECIFICITY;
SEVERITY OF ILLNESS INDEX;
|
EID: 33645933900
PISSN: 17103568
EISSN: None
Source Type: Journal
DOI: 10.2310/6620.2006.05045 Document Type: Article |
Times cited : (47)
|
References (11)
|